Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	106,845	114,152	91,081	42,146	35,617	27,480
Market Cap Growth	62.99%	25.33%	116.11%	18.33%	29.61%	-19.18%
Enterprise Value	149,223	161,627	150,359	109,242	106,456	99,359
Last Close Price	92.75	100.90	81.01	38.15	32.99	26.95
PE Ratio	23.77	25.40	-	-	-	21.19
PS Ratio	1.94	2.08	1.51	0.74	0.68	0.56
PB Ratio	4.23	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	29.19	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	20.32	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	2.79	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	9.43	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	12.14	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	40.77	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.39	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	15.01	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.73	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	2.76	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	11.91	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	6.17%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	18.07%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	14.50%	14.50%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	4.21%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	3.43%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.